Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Director/PDMR Shareholding

18 Sep 2015 18:18

RNS Number : 5875Z
Circassia Pharmaceuticals Plc
18 September 2015
 



18 September 2015

Circassia Pharmaceuticals plc

 

Director Dealing

 

Circassia Pharmaceuticals plc ("Circassia" or "the Company") hereby provides notification that it was informed today that Charles Swingland, 63, a Non-Executive Director of the Company, sold the following shares as detailed below:

Class of share

Number of shares sold

Average price

Date on which shares were sold

Ordinary shares of 0.08 pence each

1,230,000

318.24p

16 September 2015

Ordinary shares of 0.08 pence each

9,000

318.72p

17 September 2015

Ordinary shares of 0.08 pence each

754,548

320.24p

18 September 2015

 

Following the above transactions, Charles Swingland retains 65.16 per cent. of his holding prior to these transactions, and now holds 3,728,129 Ordinary Shares representing 1.31 per cent. of the Company's total voting rights.

 

-Ends-

 

For further information, please contact:

Circassia Pharmaceuticals plc

Julien Cotta, Company Secretary

+44 (0) 1865 405560

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBRGDCSBBBGUI
Date   Source Headline
17th Aug 20059:43 amRNSDirectorate Changes
18th Jul 200511:04 amRNSSAR 3 - Capricorn Resources
15th Jul 20054:36 pmRNSBoard changes & shareholdings
30th Jun 20057:00 amRNSFinal Results
19th Apr 20052:16 pmRNSAdditional Listing
7th Feb 20052:33 pmRNSPossible acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.